| Market Capitalization (Millions $) |
9 |
| Shares
Outstanding (Millions) |
8 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-16 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Indaptus Therapeutics Inc
Indaptus Therapeutics Inc is a pharmaceutical company that focuses on developing innovative therapies for the treatment of various diseases. The company's main area of expertise lies in the field of gene therapy and genetic medicine.
Indaptus Therapeutics Inc utilizes cutting-edge technology and research to identify and develop gene therapies that target specific genetic mutations and diseases. This approach holds great potential for the treatment of genetic disorders that currently have limited or no treatment options.
The company's goal is to bring forward transformative therapies that can improve patient outcomes and quality of life. Indaptus Therapeutics Inc collaborates with leading academic institutions and research organizations to advance its pipeline of therapeutics.
With a strong focus on precision medicine, Indaptus Therapeutics Inc aims to develop personalized therapies that are tailored to individual patients' genetic profiles. This approach has the potential to revolutionize the way diseases are treated by addressing the underlying genetic causes.
Overall, Indaptus Therapeutics Inc is dedicated to pushing the boundaries of medicine and making a lasting impact in the field of gene therapy, with the ultimate objective of improving the lives of patients suffering from genetic diseases.
Company Address: 3 Columbus Circle New York 10019 NY
Company Phone Number: 427-2727 Stock Exchange / Ticker: NASDAQ INDP
|
1.11% 